Extracellular matrix remodeling in chronic liver disease
GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists These agents are commonly used therapies for managing diabetes and obesity, but gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
Asia Pacific is the fastest-growing region in the GLP-1 analogues market, propelled by the rising incidence of lifestyle-related disorders, expanding healthcare access, and a growing middle-class population seeking advanced therapies
Its once-weekly injectable regimen improves patient adherence compared with daily treatments, offering convenience without sacrificing outcomes
They also have to go through significant pre-surgical counseling and preparation that can take months
Prescribing & titration is anticipated to lead Service Scope with 46.0% share in 2026